The cellular marker cluster of differentiation (CD68) has been widely used as a pan-macrophage marker in most studies; however, it has been reported that CD68 occasionally expressed in dendric cells, stromal cells, even cancer cells (12), indicating that any biological materials targeting CD68+ TAMs might be off-target. This evidence concerns the gene CD68 and cancer.